The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Goriaĭnov S.A.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Potapov A.A.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Pitskhelauri D.I.

Burdenko Neurosurgical Center

Kobiakov G.L.

GBU NII neĭrokhirurgii im. N.N. Burdenko

Okhlopkov V.A.

GBOU "Omskaia gosudarstvennaia meditsinskaia akademiia" Ministerstva zdravookhraneniia Rossiĭskoĭ Federatsii

Gavrilov A.G.

N.N. Burdenko Institute of Neurosurgery, Moscow, Russia

Shurkhaĭ V.A.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Zhukov V.Iu.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN

Shishkina L.V.

Burdenko Neurosurgery Institute, Moscow, Russia

Loshchenov V.B.

Institut obshcheĭ fiziki im. A.M. Prokhorova RAN

Savel'eva T.A.

Institut obshcheĭ fiziki im. A.M. Prokhorova RAN

Kuz'min S.G.

Research Institute of Clinical Oncology at N.N. Blokhin Oncological Research Centre

Chumakova A.P.

Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova, Moskva

Spallone A.

Otdel neĭrokhirurgii Instituta neĭronauk, Rim, Italiia

Intraoperative fluorescence diagnostics upon recurrent operations for brain gliomas

Authors:

Goriaĭnov S.A., Potapov A.A., Pitskhelauri D.I., Kobiakov G.L., Okhlopkov V.A., Gavrilov A.G., Shurkhaĭ V.A., Zhukov V.Iu., Shishkina L.V., Loshchenov V.B., Savel'eva T.A., Kuz'min S.G., Chumakova A.P., Spallone A.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2014;78(2): 22‑31

Read: 1540 times


To cite this article:

Goriaĭnov SA, Potapov AA, Pitskhelauri DI, et al. . Intraoperative fluorescence diagnostics upon recurrent operations for brain gliomas. Burdenko's Journal of Neurosurgery. 2014;78(2):22‑31. (In Russ., In Engl.)

Recommended articles:
Anti­depressants as addi­tional drugs for human brain gliomas. Burdenko's Journal of Neurosurgery. 2024;(6):97-102
Glymphatic system in health and disease: a narrative review. Burdenko's Journal of Neurosurgery. 2025;(4):112-118
Non-invasive auto­mated methods for the diagnosis of periorbital skin tumors. Russian Annals of Ophthalmology. 2024;(5):137-145

References:

  1. Goryaynov S.A., Potapov A.A., Gol’bin D.A., Zelenkov P.V., Kobyakov G.L., Gavrilov A.G., Okhlopkov V.A., Shurkhay V.A., Shelesko E.V., Zhukov V.Yu., Loshchenov V.B., Savel’eva T.A., Kuz’min S.G. Fluorescence diagnosis and laser biospectroscopy as one of the methods of multimodal neuronavigation in neurosurgery. Vopr Neyrokhir 2012; 6: 57-65. In Russian.
  2. Malkarov M.S. Intraoperative fluorescent and ultrasonic control in surgery of intracerebral tumors: Summary of the Candidate of Medicine Thesis. Moscow 2011. In Russian.
  3. Malkarov M.S., Dreval’ O.N., Borzunov A.N., et al. Methods of intraoperative control during removal of intracerebral tumors of the brain. Vopr Neyrokhir 2010; 3: 20-25. In Russian.
  4. Potapov A.A., Gavrilov A.G., Goryaynov S.A., Gol’bin D.A., Zelenkov P.V., Kobyakov G.L., Okhlopkov V.A., Zhukov V.Yu., Shishkina L.V., Shurkhay V.A., Loshchenov V.B., Savel’eva T.A., Grachev P.V., Kholodtsova M.N., Kuz’min S.G., Vorozhtsov G.N. Intraoperative fluorescence diagnosisand laser spectroscopy in surgery of brain glial tumors. Vopr Neyrokhir 2012; 5: 3-12. In Russian.
  5. Potapov A.A., Goryaynov S.A., Loshchenov V.B., Savel’eva T.A., et al. Intraoperative combined spectroscopy (optical biopsy) of brain gliomas. Vopr Neyrokhir 2013; 2: 3-10. In Russian.
  6. Skvortsova T.Yu., Brodskaya Z.L., Savintseva Zh.I. Modern methods of neurovisualization in differential diagnosis of radiation injuries of the brain in patients with cerebral tumors. Byul sib med 2011; 4: 130-136. In Russian.
  7. Sokolov V.V., Filonenko E.V., Telegina L.V., Bulgakova N.N., Smirnov V.V. Combination of fluorescent imaging of local spectrophotometry in fluorescence diagnostics of early cancer of the larynx and bronchi. Kvant elektronika 2002; 32: 11: 963-969. In Russian.
  8. Ammirati M., Galicich J.H., Arbit E., Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 1987; 21: 5: 607-614.
  9. Ando T., Kobayashi E., Liao H., Maruyama T., Muragaki Y., Iseki H., Kubo O., Sakuma I. Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identification. Brain Tumor Pathol 2011; 28: 1: 43-51.
  10. Bloch O., Han S.J., Cha S., Sun M.Z., Aghi M.K., McDermott M.W., Berger M.S., Parsa A.T. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 2012; 117: 6: 1032-1038. doi: 10.3171/2012.9.JNS12504.
  11. Brandes A.A., Bartolotti M., Franceschi E. Second surgery for recurrent glioblastoma: advantages and pitfalls. Exp Rev Anticancer Ther 2013; 13: 5: 583-587. doi: 10.1586/era.13.32.
  12. Carson K.A., Grossman S.A., Fisher J.D., Shaw E.G. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol 2007; 25: 18: 2601-2606.
  13. Clarke J.L., Ennis M.M., Yung W.K., Chang S.M., Wen P.Y., Cloughesy T.F., Deangelis L.M., Robins H.I., Lieberman F.S., Fine H.A., Abrey L., Gilbert M.R., Mehta M., Kuhn J.G., Aldape K.D., Lamborn K.R., Prados M.D. North American Brain Tumor Consortium. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol 2011; 13: 10: 1118-1124. doi: 10.1093/neuonc/nor110.
  14. Crocetti E., Trama A., Stiller C. et al. RARECARE working group. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer 2012; 48: 10: 1532-1542.
  15. De Bonis P., Anile C., Pompucci A., Fiorentino A., Balducci M., Chiesa S., Lauriola L., Maira G., Mangiola A. The influence of surgery on recurrence pattern of glioblastoma. Clin Neurol Neurosurg 2013; 115: 1: 37-43. doi: 10.1016/j.clineuro.2012.04.005.
  16. Gorlia T., Stupp R., Brandes A.A., Rampling R.R., Fumoleau P., Dittrich C., Campone M.M., Twelves C.C., Raymond E., Hegi M.E., Lacombe D., van den Bent M.J. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials. Eur J Cancer 2012; 48: 8: 1176-1184. doi: 10.1016/j.ejca.2012.02.004.
  17. Guyotat J., Signorelli F., Frappaz D., Madarassy G., Ricci A.C., Bret P. Is reoperation for recurrence of glioblastoma justified? Oncol Rep 2000; 7: 4: 899-904.
  18. Kamp M.A., Grosser P., Felsberg J., Slotty P.J., Steiger H.J., Reifenberger G., Sabel M. 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 2012; 154: 2: 223-228; discussion 228.
  19. Kostron H., Bauer R. Management of recurrent malignant glioma-neurosurgical strategies. Wien Med Wochenschr 2011; 161: 1-2: 20-21.
  20. Landy H.J., Feun L., Schwade J.G., Snodgrass S., Lu Y., Gutman F. Retreatment of intracranial gliomas. South Med J 1994; 87: 2: 211-214.
  21. Mandl E.S., Dirven C.M., Buis D.R., Postma T.J., Vandertop W.P. Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy. Surg Neurol 2008; 69: 5: 506-509; discussion 509.
  22. McGirt M.J., Chaichana K.L., Gathinji M. et al. Independent association of extent of with survival in patients with malignant brain astrocytoma. J. Neurosurg 2009; 110: 1: 156-162.
  23. Mirimanoff R.O. et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/ 22981-NCIC CE3 phase III randomized trial. J Clin Oncol 2006; 24: 16: 2563-2569.
  24. Miyatake S., Kuroiwa T., Kajimoto Y., Miyashita M., Tanaka H., Tsuji M. Fluorescence of non-neoplastic, magnetic resonance imaging-enhancing tissue by 5-aminolevulinic acid: case report. Neurosurgery 2007; 61: 5: E1101-E1103; discussion E1103-E1104.
  25. Nabavi A., Thurm H., Zountsas B., Pietsch T., Lanfermann H., Pichlmeier U., Mehdorn M. 5-ALA Recurrent Glioma Study Group. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery 2009; 65: 6: 1070-1076; discussion 1076-1077. doi: 10.1227/01.NEU.0000360128.03597.C7.
  26. Nakajima T., Kumabe T., Kanamori M. et al. Differential di-agnosis between radiation necrosis and glioma orogression using sequential proton magnetic resonance spectroscopy and methionine positrin emission tomography. Neurol Med Chir (Tokyo) 2009; 49: 394-401.
  27. Nazzaro J.M., Neuwell E.A. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 1990; 73: 331-334.
  28. Pinsker M., Lumenta C. Experiences with reoperation on recurrent glioblastoma multiforme. Zentralbl Neurochir 2001; 62: 2: 43-47.
  29. Stummer W., Pilchmeier U., Meinel T. et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 2007; 7: 392-401.
  30. Stupp R., Hegi M.E., Mason W.P. et al. European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 2009; 10: 5: 459-466.
  31. Stupp R., Mason W.P., van den Bent M.J. et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 10: 987-996.
  32. Terakawa Y., Tsuyuguchi N., Iwai Y. et al. Diagnostic accu-racy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 2008; 49: 694-699.
  33. Tonn J.C., Stummer W. Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Clin Neurosurg 2008; 55: 20-26.
  34. Utsuki S., Oka H., Sato S., Suzuki S., Shimizu S., Tanaka S., Fujii K. Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. J Neurosurg 2006; 104: 4: 618-620.
  35. Valdés P.A., Kim A., Brantsch M., Niu C., Moses Z.B., Tosteson T.D., Wilson B.C., Paulsen K.D., Roberts D.W., Harris B.T. δ-Aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. Neuro Oncol 2011; 13: 8: 846-856.
  36. Valdés P.A., Leblond F., Kim A., Harris B.T., Wilson B.C., Fan X., Tosteson T.D., Hartov A., Ji S., Erkmen K., Simmons N.E., Paulsen K.D., Roberts D.W. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg 2011; 115: 1: 11-17.
  37. Yoshii Y. Pathological review of late cerebral radionecrosis. Brain Tumor Pathol 2008; 25: 51-58.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.